|Bid||63.92 x 1800|
|Ask||64.00 x 800|
|Day's Range||62.65 - 65.21|
|52 Week Range||23.55 - 80.51|
|PE Ratio (TTM)||N/A|
|YTD Daily Total Return||-9.26%|
|Beta (5Y Monthly)||2.48|
|Expense Ratio (net)||1.08%|
Inside the top-and-worst-performing leveraged ETFs of last week.
Merger and acquisitions (M&A) activity within the healthcare industry heightened last year, according to recent research data and this could feed into gains for M&A and healthcare-focused ETFs for traders sensing an opportunity. “The U.S. healthcare market saw a 14.4 percent increase in mergers and acquisitions from 2017-2018, fueled by soaring domestic venture capital investment – an all-time high of $130.9 billion invested in U.S.-based startups in 2018 alone,” a press release by Sage Growth Partners said. "Business opportunities in healthcare today are driven by two key factors – the industry's widespread waste and inefficiencies, and public and private sector mandates to reduce costs while increasing health outcomes," said Dan D'Orazio, SGP's CEO.
Inside the best five best leveraged ETFs of November.